These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27815294)

  • 1. Q&A: Omid Farokhzad on Nanomedicine in Cancer.
    Cancer Discov; 2016 Dec; 6(12):1300. PubMed ID: 27815294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 3. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 4. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanostructure-Based Theranostic Systems.
    Wang J; Cui H
    Theranostics; 2016; 6(9):1274-6. PubMed ID: 27375778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting clinical translation of nanomedicine.
    Jang HL; Zhang YS; Khademhosseini A
    Nanomedicine (Lond); 2016 Jun; 11(12):1495-7. PubMed ID: 27176482
    [No Abstract]   [Full Text] [Related]  

  • 7. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges of moving theranostic nanomedicine into the clinic.
    Singh D; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2020 Jan; 15(2):111-114. PubMed ID: 31903854
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial Molecular Machines in Nanotheranostics.
    Yu G; Yung BC; Zhou Z; Mao Z; Chen X
    ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Issue "Recent Advances in Precision Nanomedicine for Cancer".
    Brignole C; Pastorino F
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond.
    Mitragotri S; Lammers T; Bae YH; Schwendeman S; De Smedt S; Leroux JC; Peer D; Kwon IC; Harashima H; Kikuchi A; Oh YK; Torchilin V; Hennink W; Hanes J; Park K
    J Control Release; 2017 Jan; 246():183-184. PubMed ID: 28110715
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 14. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
    Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
    Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
    Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
    Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 18. Theranostic nanomedicine of gold nanoclusters: an emerging platform for cancer diagnosis and therapy.
    Muthu MS; Agrawal P; Singh S
    Nanomedicine (Lond); 2016 Feb; 11(4):327-30. PubMed ID: 26784106
    [No Abstract]   [Full Text] [Related]  

  • 19. Facilitating Translational Nanomedicine via Predictive Safety Assessment.
    Mirshafiee V; Jiang W; Sun B; Wang X; Xia T
    Mol Ther; 2017 Jul; 25(7):1522-1530. PubMed ID: 28412168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.